Hyperfine

Global Aging And Telemedicine Will Drive Portable MRI Adoption

AnalystHighTarget

Not Invested

Community Contributor

Published

14 Aug 25

AnalystHighTarget's Fair Value

US$2.00

12.5% undervalued

11 Sep

US$1.75

76.0%

15.1%

76.0%

15.1%

You can edit this narrative until Aug 14 9:18 PM. Then, changes will post as Updates.

Author's Valuation

US$212.5% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$2

12.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

21.86%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.36%

Calculation

US$2.99m

Earnings '28

79.46x

PE Ratio '28

US$237.84m

Market Cap '28

US$237.84m

Market Cap '28

98.22m

No. shares '28

US$2.42

Share Price '28

US$2.42 Share Price '28

Discounted to 2025 @ 7.40% p.a.

US$1.95

Fair Value '25